Abbott Reports Fourth-Quarter and Full-Year 2023 Results; Issues 2024 Financial Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
Abbott (ABT) slips as results, guidance barely meet consensus
January 24, 2024 7:47 AM ESTAbbott (NYSE: ABT) reported fourth-quarter results that met average analyst estimates. Shares fell 2% in response to the released figures.
Adjusted earnings per share (EPS) of $1.19 and revenue of $10.24 billion were in line with the market consensus.
"The strength and diversity of the... More
Abbott (ABT) Reports In-Line Q4 EPS, Offers Guidance
January 24, 2024 7:31 AM ESTAbbott (NYSE: ABT) reported Q4 EPS of $1.19, in-line with the analyst estimate of $1.19. Revenue for the quarter came in at $10.24 billion versus the consensus estimate of $10.17 billion.
GUIDANCE:
Abbott sees FY2024 EPS of $4.50-$4.70, versus the consensus of $4.63.
For earnings history and earnings-related data on Abbott (ABT) click here.
... More